I. Introduction
Multiple therapies are becoming extremely useful in pharmaceutical dosage forms. As the result, numerous and various combinations of drugs are being introduced into the market. Out of these, antiHypertensive drugs are one of the mostly prescribed cardiovascular drugs. Amlodipine is a drug used to lower blood pressure and prevent the pain in the chest. It belongs to a group of drugs known as calcium channel blockers [1, 2] .Amlodipine inhibits calcium ion influx across cell membrane. The chemical name of Amlodipine is [2-(Amino ethoxy) methyl] -4 -(2-chlorophenyl) -3 -ethoxycarbonyl-5-methoxycarbonyl-6-methyl 1,4dihydropyridine benzene Sulfonate [2] .Perindopril, or perindopril arginine, is a long-acting ACE inhibitor [3] [4] . ACE (angiotensin-converting enzyme) inhibitors, including peridopril, are commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease [5] . Perindopril Arginineis chemically 2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid [6] .
The main function of this ACE inhibitor is to decrease the action. The molecular formula of perindopril arginine and perindopril erbumine is different but their therapeutic action is very similar [6] . Literature review shows several methods has been developed and reported for AML andPEAestimation in biological fluids and there are some methods reported by [10] , spectroscopy [11] [12] [13] , HPTLC, HPLC, UPLC and capillary electrophoresis [14] [15] [16] . Two methods were reported for estimation of this combination first is UV spectroscopy [17] [18] [19] and the other is HPTLC method [20, 21] . Method development of HPLC estimation for this combination is new method will fulfil all requirements of validation according to ICH guidelines.
II. Materials And Methods
The working standard of Amlodipine,Perindopril argininewas purchased from Sigma, UK. The Marketed sample ofPrestaliastrength Amlodipine2.5mg Perindopril arginine3.5mg manufactured by PatheonPharamcceuticals and marketed by Symplmed Pharmaceuticals USA purchased from the local Pharmacy, Germany. Methanol HPLC grade was purchased from Merck, Darmstadt, Germanyand phosphoric acids purchased from Fisher Scientific (UK).
III. Instrumentation

HPLC instrumentation and chromatographic condition:
HPLC system of Shimadzu LC-20 AT, with an auto sampler (SIL-20ACHT, Shimadzu, Japan) and SPD-10 detector (SPD-M20A, Japan) was used. 
Preparation of Mobile phase:
Phosphate buffer was prepared using1.35gof KH 2 PO 4 in 500 ml of HPLC grade water by using phosphoric acid pH adjusted to 6. It was filtered with 0.45μ membrane filters and degassed in an ultrasonic bath for 10 minutes. The ratio of final mobile phase isMethanol: phosphate buffer (27:73 v/v).
Preparation of Amlodipine (AML)
,Perindopril (PEA) Stock solution: Accurately 1 mg of AML (RS) andPEA (RS) was taken separately in 100 ml volumetric flasks and mixed with 25 ml of mobile phase solutionand sonicated for 10 minutes and 75ml of mobile phase was added to the mark and cooled to room temperature. To get the concentration of 2-10μg/mlof AML and 3-15μg/ml of PEAvarying quantities of standard stock solution was diluted with mobile phase. The twoAML and PEApowder freely soluble in methanol and does not have any interference in the absorption peaks.
Preparation of sample solution:
10 tablets of marketed sample of Prestalia weighedaccurately andpowder equivalent of 2.5 mg of AML and 3.5 mg PEA transferred into 25mlvolumetric flasks and dissolved with 25 ml mobile phase and the resulting solution was filtered through Whatmanfilter paper.Further dilutions were made based on the required concentrations.
Method validation:
The present method was preceded to obtain new, sensitive and easy method for simultaneous estimation by HPLC from capsule formulation. According to the ICH guidelines recommendations the experimental was validated and USP-30 for parameters such as, system suitability, accuracy, precision, linearity and specificity.
System suitability:
System suitability parameters like resolution, retention time, tailing factor and column theoretical plates was performed by injecting six replicates of standards and two replicates of sample preparation at a 100% level to cross verify the accuracy and precision of the chromatographic system.
3.7.Linearity:
The chromatographic method linearity was established by plotting a graph to concentration vs peak area of AML andPEAstandard and determining the correlation coefficients (R2) of the two compounds.
For the linearity studies of 2-10 μg/ml of AML, 3-15μg/ml of PEArespectively was injected into the HPLC system. For 60 minutes column was equilibrated with the mobile phase before injection of the solutions.
Accuracy:
The recovery experiments show the accuracy of the method. The recovery was performed by adding AML andPEAworking standards to placebo (excipients mixture) in the range of test concentration (60%, 80% and 100 %) and expressed as percent (%) recovered. Three samples were prepared for each recovery level. The recovery statistical results are within the acceptance range (S.D. < 2.0) value for AML andPEA.
Precision:
In the proposed method the intraday and interday precision was determined by analyzing the sample responses 4 repeats on the same day and 4 different days of a week for 4 different concentrations of standard solutions of AML and PEA. 4-10 μg/mlof AML and6-15μg/ml of PEArespectively and results are represented in terms of % RSD.
Specificity:
The analytical method specificity is to measure the compound accurately in presence of interferences like excipients, degradants and matrix components. TheHPLC of standard mixture and formulation shows specificity of method. TheHPLC method is able to access the analyte in presence of excipients.
Statistical Parameters:
The results of assay obtained are subjected to the following statistical analysis, standard deviation, relative standard deviation, coefficient of variation and standard error.
IV. Results And Discussion
The HPLCchromatogram of AML andPEAare presented in figure 1,2. Wavelength270nm was selected by scanning all standard drugs over a wide range of wavelength 200-400nm. Linearity was evaluated by plotting peak area as a functional of analyte concentration for AML andPEA. The graphical representation was given in figure 3 and4 data is presented in table 1. The system suitability parameters like resolution, tailing factor, retention time and theoretical plates for the developed RP-HPLC method data are presented in table 2. The limit of detection and limit of quantification for AML and PEA are presented in table 3.
Simultaneous determination and estimation of
The specific range was determined from linearity studies, for both drugs and found to be 2-10 μg/ml of AML and 3-15 μg/ml of PEA. The data was analyzed by linear regression least square fit method. The slope, intercept, correlation coefficient and regression equation were also determined and the data presented in table 4 .
TheAML andPEAchromatographic retention time found to be 4.2 and 7.3 minutes respectively. This is well within the specific limits of 15 minutes. The high -resolution of AML andPEAindicates complete separation of the drugs. The tailingfactor was found to be 0.769 and 0.780 for AML andPEArespectively. The peaks are symmetrical and theoretical plates for AML andPEAwere 7065, and 7952 respectively, which shows the column efficient performance. The quantitative estimation of AML andPEA tabletformulation was carried out by RP-HPLC method using Methanol: Phosphate buffer (27:73 v/v) using C18 column as the stationary phase.Chromatogram ofAML andPEA tablet formulation shown in the figure 5.Quantitative estimation (Assay) data of AML andPEApresented in table 5.Recovery studies of AML andPEA tablet formulation shown in table 6 .
The tablet formulation shows percentage purity ranging from 99.16 to 100.18% for AML and99.58 to 100.23% for PEA.The mean percentage purity is 100.01% and 100.08% forAML andPEArespectively. The percentage deviation was found to be -1.0 to +1.0% and -0.6 to +0.7, for AML andPEArespectively. The RSD values are below 2% indicating the method precision and the accuracy of the method shown by the low standard error values. This shows a good index of accuracy and reproducibility of the developed method. All the parameters including flow rate, detection wavelength sensitivity was maintained constant. Table 6 :Recovery studies of Amlodipine andPerindopriltablet formulation
V. Figures And Tables
VI. Conclusion
The proposed and developed RP-HPLC method is precise, accurate, and sensitive. The method is rapid, reproducible, and economical and does not have any interference due to the excipients in the pharmaceutical preparations.
